Abstract
Milestones of antibiotics research and biotechnology in Jena/Thuringia are: 1938 — Hans Knöll established a strain collection of microorganisms; 1942 — production of penicillin on laboratory scale by Hans Knöll; since 1945 — development of industrial production processes for penicillin and streptomycin; 1952 — production of BCG-vaccine; since 1956 — development of biotechnical processes in the Institute of Microbiology and Experimental Therapy for actinomycin C, oxytetracyclin, erythromycin, paromomycin, turimycin, griseofulvin, nystatin, and nourseothricin, and in the 1980s for streptokinase, staphylokinase, and interferons. After the German unification the Hans-Knöll-Institute for Natural Products Research was founded.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bocker, H., Knorre, W.A. (2000). Antibiotica Research in Jena from Penicillin and Nourseothricin to Interferon. In: Fiechter, A. (eds) History of Modern Biotechnology II. Advances in Biochemical Engineering/Biotechnology, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-44965-5_2
Download citation
DOI: https://doi.org/10.1007/3-540-44965-5_2
Received:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67792-5
Online ISBN: 978-3-540-44965-2
eBook Packages: Springer Book Archive